1α,25-Dihydroxyvitamin D3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin
- 31 October 1983
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 116 (2), 605-611
- https://doi.org/10.1016/0006-291x(83)90567-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Diazepam inhibition of phorbol ester tumor promotionCancer Letters, 1983
- Induction of differentiation of human promyelocytic leukemia (HL-60) cells by teleocidin and phorbol-12-myristate-13-acetateCarcinogenesis: Integrative Cancer Research, 1982
- 1α,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cellsBiochemical and Biophysical Research Communications, 1981
- Intracellular calcium and skin tumor promotion: Calcium regulation of the induction of epidermal ornithine decarboxylase activity by the tumor promoter 12-O-tetradecanoylphorbol-13-acetateBiochemical and Biophysical Research Communications, 1981
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981
- Current concepts and controversies in chemical carcinogenesisJournal of Supramolecular Structure and Cellular Biochemistry, 1981
- 1,25-dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells)Biochemical and Biophysical Research Communications, 1980
- Rapid alteration in Ca++ content and fluxes in phorbol 12-myristate 13-acetate treated myoblastsBiochemical and Biophysical Research Communications, 1980
- Prostaglandin modulation of phorbol ester skin tumor promotionCarcinogenesis: Integrative Cancer Research, 1979
- Fluocinolone acetonide: A potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesisChemico-Biological Interactions, 1977